Pharmaniaga Bhd MYX:PHARMA:
Q1 2026 PROFIT ATTRIBUTABLE TO EQUITY HOLDERS 31.5 MILLION RGT VERSUS 29.6 MILLION RGT YEAR AGO
Q1 2026 REVENUE 1178.5 MILLION RGT VERSUS 1055.3 MILLION RGT YEAR AGO
Q1 2026 PROPOSED DIVIDEND PER SHARE 0.25 SEN
Pharmaniaga Bhd MYX:PHARMA:
Q1 2026 PROFIT ATTRIBUTABLE TO EQUITY HOLDERS 31.5 MILLION RGT VERSUS 29.6 MILLION RGT YEAR AGO
Q1 2026 REVENUE 1178.5 MILLION RGT VERSUS 1055.3 MILLION RGT YEAR AGO
Q1 2026 PROPOSED DIVIDEND PER SHARE 0.25 SEN